CAS 943609-66-3

Vedolizumab

CAS: 943609-66-3

Vedolizumab

Formel: C₄₈H₄₈N₁₂O₆

Reinheit: 95%

Molekulargewicht: 888.97

Ref: 54-OR1139139

Vedolizumab

CAS: 943609-66-3

Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of Crohn's disease and ulcerative colitis.

Reinheit: SDS-PAGE:98.4%;SEC-HPLC:99.1%

Farbe und Form: Liquid

Molekulargewicht: 146.80 kDa

Ref: TM-T9914

Vedolizumab

CAS: 943609-66-3

Inhibits lymphocyte adhesion to mucosal endothelium; Crohn's disease therapy

Reinheit: Min. 95%

Ref: 3D-BV165597